Latest

What's New in Obesity Treatment? — Photo by Khuram Naseem on Pexels

semaglutide

From 20% Weight Loss to 28% in 12 Weeks: Tirzepatide Shows Best ROI for Obesity Treatment in a Budget‑Conscious Practice

Semaglutide and tirzepatide are the most effective prescription weight-loss drugs currently approved in the United States. Both agents act like thermostats for hunger, resetting appetite signals and enabling sustained calorie reduction when paired with lifestyle counseling. Their clinical results, cost structures, and insurance barriers shape how clinicians deploy obesity treatment